Effective management of idiopathic hypersomnia (IH) may significantly reduce the incidence and severity of associated depressive symptoms and suicidal thoughts.

Avadel Pharmaceuticals (AVDL) is undervalued, with $2B+ sales potential and key catalysts ahead. Read here for more analysis.

Jazz Pharmaceuticals' growth is anchored by Xywav and Epidiolex, both generating robust sales and supporting future oncology pipeline expansion. Read why JAZZ is a Buy.

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the best affordable biotech stocks to invest in now. On September ...

Jazz Pharma is redefining cannabis investing with Epidiolex, a fast-growing FDA-approved epilepsy drug fueling its growth.

Oversleeping, exceeding the recommended seven to nine hours, can paradoxically trigger headaches by disrupting brain chemicals like serotonin and disturbing the body's natural circadian rhythm. This ...

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) released topline results from its Phase 3 registrational clinical trial (the ...

Harmony Biosciences reveals disappointing results from the Phase III Reconnect study of ZYN002 for Fragile X Syndrome, ...

Insufficient sleep can trigger low-grade inflammation in the body, which may slowly harm the organs and accelerate the brain ...

A Crown prosecutor cast doubt on Zain Xavier Wood’s testimony that he was high on methamphetamine on the day he stabbed ...

Harmony Biosciences said on Wednesday its experimental drug for a rare genetic disorder failed to meet the main goal in a late-stage trial, sending its shares down more than 8%.

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical ...